Second Raya CARES compound to be evaluated in the UK's NIHR-funded ALS platform trial with both compounds expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results